Cluzeau, T., Sebert, M., Rahmé, R., Cuzzubbo, S., Lehmann-Che, J., Madelaine, I., . . . Fenaux, P. (2021). Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM). J Clin Oncol.
Citação norma ChicagoCluzeau, Thomas, et al. "Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study By the Groupe Francophone Des Myélodysplasies (GFM)." J Clin Oncol 2021.
Citação norma MLACluzeau, Thomas, et al. "Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study By the Groupe Francophone Des Myélodysplasies (GFM)." J Clin Oncol 2021.